No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Editor's Pick

Trump’s First 100 Days: Health Policy

by
April 30, 2025
in Editor's Pick
0
Trump’s First 100 Days: Health Policy
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Michael F. Cannon

How did the Trump administration perform on health policy in its first 100 days? A flurry of activity is not the same as progress. 

President Trump has taken positive steps on health policy, such as withdrawing former President Biden’s unlawful plan to have Medicare cover weight-loss drugs. But he has been unforgivably AWOL on the dire need for fundamental reform of Medicare, Medicaid, CHIP, Obamacare, the VHA, and the FDA. And his administration has intemperately cast doubt on the efficacy of vaccines, the most beneficial medical interventions in human history. 

Many Trump actions that could potentially be positive, such as reducing the HHS workforce, may actually prove negative by paradoxically increasing government interference in health care markets. 

Many otherwise positive steps—including many spending and job cuts—appear to be ephemeral at best and, at worst, illegal. Even when the president or his advisors are trying to implement good policy, it would be better if they did nothing rather than violate the law to do it. 

Unfortunately, the president and his advisors are perpetuating a vicious and dangerous cycle of successive administrations violating the law to reward their friends, punish their enemies, and achieve ideological goals that lack democratic support.

Previous Post

The Trump Administration Is Not Serious About Ending Endless Wars

Next Post

Trump’s 100-Day Health Scorecard: Mixed Signals and Missed Marks

Next Post
Trump’s 100-Day Health Scorecard: Mixed Signals and Missed Marks

Trump’s 100-Day Health Scorecard: Mixed Signals and Missed Marks

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

Last Day to Give in 2023!

December 31, 2023

The Producer Price Index

September 9, 2023

Is Culture Degeneration Biological or Ideological?

0

0

0

0

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Recent News

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.